Ibr / Pi3 (Orig S-P Us) Lv
49 adverse event reports submitted to the FDA
Active Ingredients
Administration Routes
Species Affected
Most Affected Breeds
Most Reported Reactions
Outcome Breakdown
Data Summary
| Metric | Value |
|---|---|
| Total adverse event reports | 49 |
| Reports involving death | 45 |
| Case-fatality rate (reported events) | 9180.0% |
| Distinct species in reports | 1 |
| Distinct breeds in reports | 10 |
| Distinct reactions reported | 20 |
| Active ingredients on file | 1 |
Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.
Ibr / Pi3 (Orig S-P Us) Lv Adverse Event Insights
The FDA Center for Veterinary Medicine database currently holds 49 adverse event reports referencing Ibr / Pi3 (Orig S-P Us) Lv, including 45 reports in which the animal died — a 9180.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ibr / Pi3 (Orig S-P Us) Lv. Reported administration routes include Nasal, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.
The species most frequently named in Ibr / Pi3 (Orig S-P Us) Lv reports are Cattle (49 reports), with Cattle accounting for the largest share. Within those species, Cattle (other) (23), Aberdeen Angus (11), Crossbred Bovine/Cattle (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.
The most commonly reported clinical signs associated with Ibr / Pi3 (Orig S-P Us) Lv are Death (42), Lack of efficacy - NOS (29), Respiratory signs (7), Lack of efficacy (bacteria) - NOS (7). Of the 113 reports with a coded outcome, Died is the leading category at 38.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ibr / Pi3 (Orig S-P Us) Lv.
Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates
Read our methodology — how this data is sourced, computed, and verified.